• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NEU
Click for more information
1.06% $18.65

NEUREN PHARMACEUTICALS LIMITED - Charts / Financials

Market Cap $2.381B  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of trofinetide.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 26/04/2024 (20 minute delay) ?
Day
Open $18.85   Day High $18.92   Day Low $18.35
Daily Volume 566651
Bids   Sellers
Number Price Volume   Number Price Volume
1 $18.64 45   1 $18.73 1500

Directors & Senior Management

Mr. Jonathan Charles Pilcher Chief Executive Officer, Managing Director, Executive Director
Ms. Lauren Frazer Chief Financial Officer, Company Secretary
Mr. Larry Glass Chief Science Officer
Mr. James Shaw Vice President - Clinical and Regulatory Operations
Dr. Clive Blower Vice President - Product Development
Dr. Nancy E. Jones Vice President - Clinical Development
Mr. Gerry Zhao Vice President - Corporate Development
Ms. Virginie Durez Senior Director- Product Development and Project Management
Ms. Liza Squires Chief Medical Officer
Mr. Patrick Donald Davies Non-Executive Chairman of the Board
Ms. Dianne Angus Non-Executive Independent Director
Mr. Joseph Basile Non-Executive Independent Director
Dr. Jenny Lee Harry Non-Executive Independent Director
Dr. Trevor D. Scott Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
$18.65 		Change
-0.200(1.06%) 		Mkt cap ! $2.381B
Open High Low Value Volume
$18.85 $18.92 $18.35 $10.53M 566.6K

Buyers (Bids)

No. Vol. Price($)
1 45 $18.64
 

Sellers (Offers)

Price($) Vol. No.
$18.73 1500 1
View Market Depth
Last trade - 16.10pm 26/04/2024 (20 minute delay) ?
Last
$18.73 		  Change
-0.200 ( 0.73 %)
Open High Low Volume
$18.89 $18.89 $18.36 91292
Last updated 15.59pm 26/04/2024 ?

Top Stories

Recharged Prospects: 'Watts' on the horizon for copper & lithium

The conversation goes much deeper that this title suggests - it explores everything from projections on aluminium & manganese, to what a Donald Trump government could mean for commodities markets.
BHP confirms £31.1B takeover bid for Anglo American BHP HAS confirmed its offer to takeover fellow mining giant Anglo American plc, following press speculation of a potential deal.which had unsettled shareholder groups and financial firms in London, and provoked criticism from a South African government minister.
Raiden’s jump into lithium territory in WA’s Pilbara echoes earlier journey by Azure In its bid to define a noteworthy lithium deposit in WA’s Pilbara region, Raiden Resources is following in the footsteps of another explorer.
Lithium Universe reveals plan to fill a 'gap' in the North American market Lithium Universe has flagged its Québec Lithium Processing Hub in Canada as a key producer of battery-grade lithium to the North American market..
Regal copper grades at Gascoyne play see shares jump 33% for Augustus Augustus Minerals is reporting high grade copper rock chip results at Ti-Tree in WA based on recent fieldwork.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.